期刊文献+

鸢尾素临床应用研究进展 被引量:2

Study progress in clinical application of Irisin
下载PDF
导出
摘要 鸢尾素是近年来新发现的一种肌源性因子,可由运动诱导分泌。近年来,鸢尾素因其能够促使白色脂肪组织褐色化,进而促进人体糖脂代谢而倍受关注。鸢尾素在治疗2型糖尿病、心血管疾病、阿尔茨海默病、癌症、骨代谢等疾病方面均有一定临床应用价值。该文就鸢尾素的作用及可能机制作一综述,旨在为下一步临床研究提供方向。 Irisin is a newly discovered myogenic factor which can be induced by exercise.In recent years,Irisin has attracted much attention because of its ability to promote the browning of white adipose tissue and promote the metabolism of sugar and fat.Experimental studies have shown that Irisin has certain clinical value in the treatment of type 2 diabetes mellitus,cardiovascular disease,Alzheimer's disease,bone metabolism,cancer,and other diseases.This article will summarize the published research on Irisin at home and abroad and explore its role and possible mechanism,in order to provide direction for the next clinical research.
作者 王姝琪 王晓峰 Shu-qi Wang;Xiao-feng Wang(Department of Oral and Maxillafacial Surgery,The Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang 150001,China)
出处 《中国现代医学杂志》 CAS 北大核心 2021年第7期50-53,共4页 China Journal of Modern Medicine
关键词 鸢尾素 2型糖尿病 心血管疾病 阿尔茨海默病 癌症 irisin diabetes mellitus,type 2 cardiovascular disease Alzheimer disease cancer
  • 相关文献

参考文献1

二级参考文献13

  • 1彭红艳,常青.血管内皮细胞骨架及其与心血管疾病的关系[J].中国循环杂志,2007,22(5):394-396. 被引量:6
  • 2Booth GL, Kapral MK, Fung K, et al. Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care, 2006, 29: 32-37.
  • 3Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation, 2009, 119: 1728-1735.
  • 4Bostr6m P, Wu J, Jedrychowski MP, et al. A PGC1-ct-dependent myokine that drives brown fat like development of white fat and thermogenesis. Nature, 2012, 481: 463-468.
  • 5Moreno-Navarrete JM, Ortega F, Serrano M, et al. lrisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab, 2013, 98: E769-778.
  • 6Xiang L, Xiang G, Yue L, et al. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Atherosclerosis, 2014, 235: 328-333.
  • 7Bansilal S, Farkouh ME, Fuster ~. Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol, 2007, 99: 6B-14B.
  • 8Semenkovich CF. Insulin resistance and atherosclerosis. J Clin Invest, 2006, 116: 1813-1822.
  • 9Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003.108: 2054-2059.
  • 10Widlansky ME, Gokce N, Keaney JF, et al. The clinical implications of endothelial dysfunction. J Am Coil Cardiol, 2003, 42:1149-1160.

共引文献23

同被引文献22

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部